Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States. - Castillo JJ; Kingsley EC; Narang M; Yimer HA; Dasanu CA; Melear JM; Coleman M; Farber CM; Shulman J; Mantovani EH; Zhang X; Cohen A; et al. (EJHaem, 2023)